Cognition in the Study of Tamoxifen and Raloxifene

Completed · Phase 3 · Has a placebo group

Conditions studied: Cognition, Aging

In brief

The purpose of this study is to assess the effects of tamoxifen and raloxifene on cognitive aging in selected cognitively-healthy women.

Key facts

Study ID
NCT00687102
Run by
Wake Forest University
People needed
1498
Starts
2001-10-01
Expected to finish
2008-03-01
Last updated by the study team
2018-09-12

Who can join

Age: 65 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.